All filters
Slidesets
What Will It Take to End AIDS in Asia - Adeeba Kamarulzaman, MBBS, FRACP, FAMM, FASc, HonLLD Monash, DPMP
Presented at:
APACC 2020
Meeting
APACC 2020
Abstracts
HIV Incidence and Sexual Behaviors among Men Who Have Sex with Men Using Geosocial Networking Smartphone Application in Beijing, China: an Open Cohort Study
M. Zhang
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
High PrEP awareness and intention to use but suboptimal uptake among Hornet users in the Asia-Pacific
H. Schmidt
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Is risk compensation real? The effect of perceived level of HIV transmission risk on risk behavior in an open-label pilot PrEP-based intervention in men who have sex with men in Malaysia
K. Rankin
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Situational Analysis of HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar
A. Oo
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
PrEP or condoms, or both? Insights on risk compensation through a discrete choice experiment on PrEP preferences among gay, bisexual, and other men who have sex with men
R. Tan
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Lower prevalence of TB infection before initiating antiretroviral therapy after treatment at any CD4 in the Thai HIV National AIDS Program
W. Jantarabenjakul
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
HIV treatment outcomes among people who inject drugs in the Asia-Pacific: an observational cohort study
W. Han
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Prevalence Trend of Transmitted Drug Resistance in a Prospective Cohort of Thai People with Acute HIV Infection
C. Muccini
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Prevalence and the impact of low-level viremia among people living with HIV taking protease inhibitors or dolutegravir-based antiretroviral therapy
G. Chen
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
High retention but low virological suppression rates among HIV-infected infants with early antiretroviral treatment in the Thai national program
T. Puthanakit
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Comparison of digital and facility-based HIV/Syphilis self-testing secondary distribution modes among men who have sex with men in China
Y. Sha
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Modified self-obtained pooled sampling to screen for Chlamydia trachomatis and Neisseria gonorrhoeae infection in men who have sex with men
N. Ando
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
HCV surges among Thai MSM with HIV, fueled by crystal methamphetamine and group sex
A. Varma
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Associated factors with sexually transmitted hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan
Y. Chen
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Cost-Saving of Pooled HCV RNA Testing to Diagnose Acute HCV Infection in High-Risk Populations
H. Sun
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Drug resistance to novel non-nucleoside reverse transcriptase inhibitor Elsulfavirine among treatment-naïve, HIV-infected Caucasian and Asian patients
A. Kirichenko
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Durable efficacy of dolutegravir (DTG) plus lamivudine (3TC) in antiretroviral treatment–naive adults with HIV-1 infection: 96-week results from the GEMINI studies in participants from Asian centres
C. Yang
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Efficacy and Safety of Switching to B/F/TAF in Virologically Suppressed Asian Adults Living with HIV
A. Avihingsanon
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Pooled Analysis of the Efficacy, Safety, and Health Outcomes Following 48 Weeks of Long-acting Cabotegravir and Rilpivirine Maintenance Therapy for HIV-1 Infection in Phase 3 ATLAS and FLAIR Studies: Sub-Analysis in Asian Populations
J. Choi
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Efficacy and Safety of Switching to B/F/TAF in Virologically Suppressed Asian Women living with HIV
H. Wang
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Abstracts
Assessment of the safety of dolutegravir in HIV-infected patients from China: A real-world, open-label, multicenter, post-marketing surveillance study
F. Zhang
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020